Skip to content

Intermittent Limb Pressure Stimulation Protects Motor Cognitive Risk Syndrome in Elderly Patients

The Efficacy and Safety of Intermittent Limb Pressure Stimulation in Protecting against Motor Cognitive Risk Syndrome in Elderly Patients (INSPECT) (Sub-study of "Establishment of a program of application of multiple types of physical stimulation interventions to regulate different organismal functions")

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400091788
Enrollment
Unknown
Registered
2024-11-04
Start date
2024-11-04
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Motoric Cognitive Risk, MCR

Interventions

RIC group :Remote ischemic preconditioning
sham-RIC group:Sham remote ischemic preconditioning

Sponsors

Xuanwu Hospital Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Age 65-80 years old, gender unlimited; 2.Can live independently (4ADLs: dressing, bathing, walking, bed chair transfer); 3.MCR diagnostic criteria: Walking speed Clinical diagnosis Slow walking (single task gait test) : male 65 to 74 years old, walking speed =75 years old, walking speed =75 years old, walking speed =12 years of education) /25 minutes (<12 years of education); 4.Good compliance with treatment and follow-up is expected; 5.Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Cognitive impairment caused by clinically diagnosed neurological degenerative diseases such as Alzheimer's disease, Lewy body dementia, frontotemporal dementia, and Parkinson's disease; 2.MMSE<=23; 3.History of brain tumor or mental illness, acute stroke <=6 months; 4.Cardiothrombotic disease, such as mitral stenosis and atrial fibrillation, myocardial infarction within six months, cardiac mural thrombosis or valve neoplasms, congestive heart failure, endocarditis; 5.Obvious abnormal bleeding/coagulation mechanism; 6.Severe liver and kidney insufficiency, malignant tumors, or the presence of serious diseases requiring medical intervention or surgery; 7.RIC treatment for soft tissue or vascular injury at the cuff compression site, or other conditions that cannot tolerate RIC; 8.Known causes of slow gait (non-neurological causes such as arthritis, heart disease, and neurological causes such as hemiplegia, ataxia, spasms, Parkinson's disease, and frontal lobe disease); 9.Pregnant or lactating women; 10.Life expectancy < 6 months or expected to undergo any surgery within 6 months; 11.Refusal to sign informed consent, poor compliance, or failure to cooperate with complete treatment.

Design outcomes

Primary

MeasureTime frame
Changes in 6-month and 9-month ADAS-cog total scores from baseline;The ratio of ?ADAS-cog<=-4 for 6 months and 9 months;

Secondary

MeasureTime frame
Dementia conversion rate (MMSE) at 6 and 9 months;Fall risk at 6 months and 9 months;Changes from baseline for ADAS-cog’s 12 items at 6 and 9 months;6-month and 9-month executive ability assessment (MTT-A&B score), Social Functional Activity Questionnaire (FAQ), Daily Living Ability Scale (ADL) scores;Local skin lesions resulting from RIC physical therapy;

Countries

China

Contacts

Public ContactHaiqing Song

Xuanwu Hospital Capital Medical University

songhq@xwhosp.org+86 13701390976

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026